Morgan Stanley Lifted GE HealthCare Target to $80 in Late October, Citing Strong Orders and Backlog

GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the best digital health stocks to buy now.

Wall Street’s sentiment on GE HealthCare has remained active in recent weeks, with analysts from several firms adjusting their targets as of late October.

On October 30, 2025, Morgan Stanley raised its price target on GE HealthCare from $74 to $80 while maintaining an Equal Weight rating. In the accompanying note, analyst Patrick Wood cited solid order trends and backlog strength, stating that the firm’s hospital CapEx survey suggested a healthy demand environment. The updated forecast followed adjustments to the firm’s model after GE HealthCare’s third-quarter results.

GE HealthCare reported Q3 results on October 29, 2025. Revenue rose to about $5.1B on strength in Imaging, Advanced Visualization, and Pharmaceutical Diagnostics, with demand led by the U.S. and EMEA. Margins were pressured by tariffs and softer China, but orders grew 6% organically and guidance inched up, signaling confidence in backlog and mix.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) is a global medical technology company providing solutions in imaging, diagnostics, ultrasound, and patient monitoring. It began trading as a standalone entity in January 2023 following its spin-off from General Electric.

While we acknowledge the potential of GEHC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None.